 I-Mab NASDAQ: IMAB has collaborated with Jumpcan Pharmaceutical Group to develop, manufacture, and commercialize eftansomatropin alfa TJ101 in mainland China. Eftansomatropin alfa is I-Mabs long-acting recombinant human growth hormone. 